Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver G Ottmann

Showing results (11-20 of 102) with videos related to

Pageof 11
Sort By:
Seminars in Hematology|July 17, 2007
Current status of growth factors in the treatment of acute myeloid and lymphoblastic leukemiaOliver G Ottmann, Gesine Bug, Jürgen Krauter
Medizinische Klinik (Munich, Germany : 1983)|February 8, 2002
[Therapy of Philadelphia chromosome positive acute lymphatic leukemia (Ph+ ALL) with an inhibitor of abl-tyrosine kinase (Glivec)]Oliver G Ottmann, Barbara Wassmann, Dieter Hoelzer
Expert Opinion on Investigational Drugs|June 7, 2012
Polo-like kinases in AMLTobias Berg, Gesine Bug, Oliver G Ottmann, et al.
Haematologica|January 16, 2014
Targeting the phosphoinositide 3-kinase pathway in hematologic malignanciesElias Jabbour, Oliver G Ottmann, Michael Deininger, et al.
Leukemia & Lymphoma|May 27, 2004
Mechanisms of resistance to STI571 (Imatinib) in Philadelphia-chromosome positive acute lymphoblastic leukemiaWolf-K Hofmann, Martina Komor, Dieter Hoelzer, et al.
Leukemia Research|September 24, 2004
Development of hygromas or severe edema during treatment with the tyrosine kinase inhibitor STI571 is not associated with platelet-derived growth factor receptor (PDGFR) gene polymorphismsPatrick Brück, Barbara Wassmann, Elizabeth Ramos Lopez, et al.
Blood|November 11, 2017
CRISPR-mediated TCR replacement generates superior anticancer transgenic T cellsMateusz Legut, Garry Dolton, Afsar Ali Mian, et al.
The American Journal of Case Reports|October 17, 2017
Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment OptionsFabian Lang, Lydia Wunderle, Heike Pfeifer, et al.
Intervirology|August 26, 2011
HIV-1 infection suppresses expression of host cell cycle-associated gene PDS5AGianni Capalbo, Thea Müller-Kuller, Oliver G Ottmann, et al.
Haematologica|November 8, 2011
p185(BCR/ABL) has a lower sensitivity than p210(BCR/ABL) to the allosteric inhibitor GNF-2 in Philadelphia chromosome-positive acute lymphatic leukemiaAfsar A Mian, Anna Metodieva, Yousef Najajreh, et al.
Pageof 11

Showing results (11-20 of 102) with videos related to

Sort By:
Pageof 11
Seminars in Hematology|July 17, 2007
Current status of growth factors in the treatment of acute myeloid and lymphoblastic leukemiaOliver G Ottmann, Gesine Bug, Jürgen Krauter
Medizinische Klinik (Munich, Germany : 1983)|February 8, 2002
[Therapy of Philadelphia chromosome positive acute lymphatic leukemia (Ph+ ALL) with an inhibitor of abl-tyrosine kinase (Glivec)]Oliver G Ottmann, Barbara Wassmann, Dieter Hoelzer
Expert Opinion on Investigational Drugs|June 7, 2012
Polo-like kinases in AMLTobias Berg, Gesine Bug, Oliver G Ottmann, et al.
Haematologica|January 16, 2014
Targeting the phosphoinositide 3-kinase pathway in hematologic malignanciesElias Jabbour, Oliver G Ottmann, Michael Deininger, et al.
Leukemia & Lymphoma|May 27, 2004
Mechanisms of resistance to STI571 (Imatinib) in Philadelphia-chromosome positive acute lymphoblastic leukemiaWolf-K Hofmann, Martina Komor, Dieter Hoelzer, et al.
Leukemia Research|September 24, 2004
Development of hygromas or severe edema during treatment with the tyrosine kinase inhibitor STI571 is not associated with platelet-derived growth factor receptor (PDGFR) gene polymorphismsPatrick Brück, Barbara Wassmann, Elizabeth Ramos Lopez, et al.
Blood|November 11, 2017
CRISPR-mediated TCR replacement generates superior anticancer transgenic T cellsMateusz Legut, Garry Dolton, Afsar Ali Mian, et al.
The American Journal of Case Reports|October 17, 2017
Dasatinib and Azacitidine Followed by Haploidentical Stem Cell Transplant for Chronic Myeloid Leukemia with Evolving Myelodysplasia: A Case Report and Review of Treatment OptionsFabian Lang, Lydia Wunderle, Heike Pfeifer, et al.
Intervirology|August 26, 2011
HIV-1 infection suppresses expression of host cell cycle-associated gene PDS5AGianni Capalbo, Thea Müller-Kuller, Oliver G Ottmann, et al.
Haematologica|November 8, 2011
p185(BCR/ABL) has a lower sensitivity than p210(BCR/ABL) to the allosteric inhibitor GNF-2 in Philadelphia chromosome-positive acute lymphatic leukemiaAfsar A Mian, Anna Metodieva, Yousef Najajreh, et al.
Pageof 11